Voyageur Pharmaceuticals (CVE:VM) Shares Up 50% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price rose 50% during mid-day trading on Thursday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares were traded during mid-day trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Trading Up 11.1 %

The stock has a market cap of C$13.95 million, a PE ratio of -10.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The stock has a fifty day moving average price of C$0.07 and a 200 day moving average price of C$0.06.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.